Patients were split into two groups, an ACE high expression group and an ACE low expression group, finding that the overall survival times of HNSCC patients with high expression of ACE were longer than the patients with low ACE expression (Figure 1D). This evidence concerns the gene ACE and head and neck squamous cell carcinoma.